Single-cell Transcriptome in TME

Relying on the tumor microenvironment center technology platform, Alfa Cytology provides services for single-cell transcriptome sequencing and analysis for TME research, helping researchers successfully achieve their research goals.

Introduction

Tumor heterogeneity can generally be divided into two categories: inter-tumor heterogeneity and intra-tumor heterogeneity. Inter-tumor heterogeneity refers to the heterogeneity between different tumor tissues, for example, the heterogeneity of tumor cells between different tumor patients; intratumor heterogeneity refers to the heterogeneity between different tumor cells within the same tumor tissue. Intratumoral heterogeneity, a common feature across different tumor types, challenges current standards of care. Advances in high-throughput sequencing and imaging technologies provide opportunities to identify and characterize heterogeneity. Notably, single-cell resolution transcriptomic analysis enables quantitative measurement of molecular activities underlying cellular phenotypic diversity within tumors/tumor microenvironments. This high-dimensional data requires computational analysis to extract relevant biological insights about the cell types and states that drive tumor development and pathogenesis.

Services

Single-cell sequencing of the tumor microenvironment investigates the transcriptome at the single-cell level. Through transcriptome amplification and high-throughput sequencing, the gene structure and gene expression status of a single cell can be revealed, reflecting the heterogeneity between cells. Compared with population cell sequencing, it is more suitable for solving problems such as the research of a small number of special samples (such as tumor clinical samples) and the analysis of heterogeneous populations.

At Alfa Cytology, we have established a mature tumor microenvironment center technology platform, with a group of experienced tumor microenvironment research experts and mature technologies. Our global customers provide efficient single-cell sequencing and analysis services of tumors and microenvironments, helping you in tumor and microenvironment heterogeneity exploration, tumor progression research, and anti-tumor drug discovery.

Design

Every step from material selection, library building and sequencing, to data analysis requires scientific and meticulous design to ensure high-quality research results.

The single-cell transcriptome sequencing and analysis project for TME study of Alfa Cytology includes not only the analysis of gene structure and gene expression level, but also the classification of cell subtypes, and annotation of tumor genes and transcription factors. In addition, it also provides personalized analysis services, and the analysis content can be customized according to customer needs.

Customized information analysis can be negotiated based on customer needs.

Note: Our services list is constantly being updated and improved, please contact us by email for more up-to-date and relevant information.

Application

• The study of highly heterogeneous cells in the tumor microenvironment
• Studies with low sample/cell volume
• Genome-wide mining of gene regulatory networks
• Helps to deeply understand the process of cell differentiation, cell reprogramming, metastasis and differentiation, and related gene regulatory networks.

Service process

Alfa Cytology is dedicated to supporting scientists in making groundbreaking scientific discoveries and developing new applications to accelerate new drug discovery and scientific diagnosis and treatment. We have established the tumor microenvironment center technology platform with high performance scientific instruments and high value solutions to ensure high quality services that enable scientists to explore the mysteries of life at the tumor microenvironment level. Please let us know your project requirements and we will provide you with a comprehensive service from solution to report. If you have any questions, please feel free to contact us.

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.